ICD-10: N83.31

Acquired atrophy of the ovary, classified under ICD-10 code N83.31, refers to the pathological reduction in the size and function of the ovaries due to various acquired factors rather than congenital conditions. This condition can significantly impact a woman's reproductive health and hormonal balance.

Clinical Description

Definition

Acquired atrophy of the ovary is characterized by a decrease in ovarian size and function, which can result from several factors, including hormonal imbalances, surgical interventions, or underlying medical conditions. Unlike congenital atrophy, which is present from birth, acquired atrophy develops later in life.

Etiology

The causes of acquired atrophy of the ovary can include:

• Hormonal Changes: Conditions such as menopause lead to a natural decline in ovarian function and size due to decreased estrogen production.
• Surgical Removal: Oophorectomy, or the surgical removal of one or both ovaries, can lead to atrophy of the remaining ovarian tissue.
• Radiation or Chemotherapy: Treatments for cancers, particularly those affecting the reproductive system, can damage ovarian tissue, leading to atrophy.
• Chronic Illnesses: Conditions such as autoimmune diseases or chronic stress can also contribute to hormonal imbalances that affect ovarian health.

Symptoms

Women with acquired atrophy of the ovary may experience a range of symptoms, including:

• Irregular menstrual cycles or amenorrhea (absence of menstruation)
• Hot flashes and other menopausal symptoms
• Decreased libido
• Infertility or difficulty conceiving
• Changes in mood or cognitive function due to hormonal fluctuations

Diagnosis

Diagnosis typically involves a combination of:

• Medical History: A thorough review of the patient's medical history, including any surgical procedures, hormonal treatments, or chronic illnesses.
• Physical Examination: A gynecological examination may reveal signs of atrophy.
• Imaging Studies: Ultrasound or MRI may be used to assess ovarian size and structure.
• Hormonal Testing: Blood tests to evaluate hormone levels, particularly estrogen and follicle-stimulating hormone (FSH), can help confirm the diagnosis.

Treatment

Management of acquired atrophy of the ovary focuses on addressing the underlying causes and alleviating symptoms. Treatment options may include:

• Hormone Replacement Therapy (HRT): To alleviate menopausal symptoms and restore hormonal balance.
• Lifestyle Modifications: Diet, exercise, and stress management can support overall health and hormonal function.
• Fertility Treatments: For women seeking to conceive, assisted reproductive technologies may be considered.

Conclusion

ICD-10 code N83.31 for acquired atrophy of the ovary encompasses a condition that can significantly affect a woman's reproductive health and quality of life. Understanding the clinical aspects, including etiology, symptoms, diagnosis, and treatment options, is crucial for effective management and support for affected individuals. Proper coding and documentation are essential for healthcare providers to ensure appropriate care and reimbursement for services rendered related to this condition.

Acquired atrophy of the ovary, classified under ICD-10 code N83.31, refers to the reduction in size and function of the ovaries due to various factors, excluding congenital causes. Understanding the clinical presentation, signs, symptoms, and patient characteristics associated with this condition is crucial for accurate diagnosis and management.

Clinical Presentation

Overview

Acquired atrophy of the ovary can occur due to several underlying conditions, including hormonal imbalances, surgical interventions (such as oophorectomy), radiation therapy, or chronic diseases. The clinical presentation may vary based on the underlying cause and the patient's overall health.

Signs and Symptoms

1. Menstrual Irregularities: Patients may experience changes in their menstrual cycle, including amenorrhea (absence of menstruation) or oligomenorrhea (infrequent menstruation) due to hormonal changes associated with ovarian atrophy[1].

2. Hot Flashes and Night Sweats: These symptoms are often indicative of estrogen deficiency, which can occur with ovarian atrophy, particularly in premenopausal women[1].

3. Vaginal Dryness: Decreased ovarian function can lead to reduced estrogen levels, resulting in vaginal atrophy and dryness, which may cause discomfort during intercourse[1].

4. Decreased Libido: Hormonal changes can also affect sexual desire, leading to a reduced libido in affected individuals[1].

5. Infertility: Women with acquired ovarian atrophy may face challenges in conceiving due to diminished ovarian reserve and function[1].

6. Pelvic Pain: Some patients may report pelvic discomfort or pain, which can be associated with underlying conditions that contribute to ovarian atrophy, such as endometriosis or pelvic inflammatory disease[1].

Patient Characteristics

• Age: Acquired atrophy of the ovary is more commonly observed in women approaching menopause or those who have undergone surgical procedures affecting the ovaries. However, it can also occur in younger women due to other medical conditions[1].

• Medical History: A history of conditions such as autoimmune disorders, chronic illnesses, or previous surgeries involving the reproductive organs may increase the risk of developing ovarian atrophy[1].

• Lifestyle Factors: Factors such as smoking, excessive alcohol consumption, and poor nutrition can contribute to hormonal imbalances and may play a role in the development of ovarian atrophy[1].

• Hormonal Treatments: Women undergoing hormonal therapies, such as those for breast cancer, may experience ovarian atrophy as a side effect of treatment[1].

Conclusion

Acquired atrophy of the ovary, represented by ICD-10 code N83.31, presents with a range of symptoms primarily related to hormonal changes and reproductive health. Recognizing the signs and understanding the patient characteristics associated with this condition is essential for healthcare providers to offer appropriate management and support. If you suspect ovarian atrophy, a thorough evaluation, including hormonal assessments and imaging studies, may be warranted to determine the underlying cause and guide treatment options.

For further information or specific case management, consulting with a specialist in reproductive endocrinology or gynecology may be beneficial.

The ICD-10 code N83.31 refers specifically to "Acquired atrophy of ovary." This condition is characterized by the reduction in size and function of the ovaries, which can occur due to various factors such as hormonal changes, surgical interventions, or other medical conditions. Below are alternative names and related terms associated with this diagnosis:

Alternative Names

1. Ovarian Atrophy: A general term that describes the reduction in size and function of the ovaries.
2. Acquired Ovarian Hypoplasia: This term emphasizes the underdevelopment or reduced size of the ovaries due to acquired factors.
3. Ovarian Insufficiency: While this term often refers to a broader range of conditions affecting ovarian function, it can be related to atrophy when the ovaries fail to produce adequate hormones.
4. Ovarian Failure: This term may be used interchangeably in some contexts, particularly when atrophy leads to a complete cessation of ovarian function.

Related Terms

1. Menopause: The natural cessation of ovarian function, which can lead to atrophy over time.
2. Hypogonadism: A condition characterized by reduced hormone production from the gonads, which can result in ovarian atrophy.
3. Oophorectomy: Surgical removal of one or both ovaries, which can lead to acquired atrophy of the remaining ovarian tissue.
4. Hormonal Imbalance: Conditions that disrupt normal hormone levels can contribute to ovarian atrophy.
5. Endocrine Disorders: Disorders affecting the endocrine system can lead to changes in ovarian size and function.

Clinical Context

Understanding these alternative names and related terms is crucial for healthcare professionals when diagnosing and coding conditions associated with ovarian health. Accurate coding ensures proper treatment and management of patients experiencing symptoms related to ovarian atrophy, which may include hormonal imbalances, infertility, or other reproductive health issues.

In summary, the ICD-10 code N83.31 encompasses a range of terms that reflect the condition of acquired atrophy of the ovary, highlighting its clinical significance and the need for precise medical terminology in diagnosis and treatment.

The ICD-10 code N83.31 refers to "Acquired atrophy of ovary," which falls under the category of noninflammatory disorders of the ovary and fallopian tube. Diagnosing this condition involves a combination of clinical evaluation, imaging studies, and laboratory tests. Below are the key criteria and considerations used in the diagnosis of acquired atrophy of the ovary:

Clinical Evaluation

1. Patient History:
   - A thorough medical history is essential, including any previous surgeries, hormonal treatments, or conditions that may contribute to ovarian atrophy, such as menopause or hormonal imbalances.
   - Assessment of symptoms such as menstrual irregularities, changes in libido, or signs of estrogen deficiency.

2. Physical Examination:
   - A gynecological examination may reveal signs of atrophy, such as changes in the vaginal mucosa or pelvic organ assessment.

Imaging Studies

1. Ultrasound:
   - Transvaginal or pelvic ultrasound is commonly used to visualize the ovaries. In cases of acquired atrophy, the ovaries may appear smaller than normal, with reduced follicular activity.
   - The ultrasound can also help rule out other conditions that may mimic atrophy, such as cysts or tumors.

2. MRI or CT Scans:
   - In certain cases, advanced imaging techniques like MRI or CT scans may be utilized to provide a more detailed view of the pelvic organs and assess for any structural abnormalities.

Laboratory Tests

1. Hormonal Assessments:
   - Blood tests to measure levels of hormones such as estrogen, progesterone, and follicle-stimulating hormone (FSH) can help determine if hormonal changes are contributing to ovarian atrophy.
   - Elevated FSH levels, in conjunction with low estrogen levels, may indicate ovarian insufficiency or atrophy.

2. Other Tests:
   - Depending on the clinical scenario, additional tests may be warranted to rule out other endocrine disorders or conditions affecting ovarian function.

Differential Diagnosis

• It is crucial to differentiate acquired atrophy from other conditions that may affect ovarian size and function, such as:
• Ovarian hyperstimulation syndrome
• Polycystic ovary syndrome (PCOS)
• Ovarian tumors or cysts
• Congenital anomalies

Conclusion

The diagnosis of acquired atrophy of the ovary (ICD-10 code N83.31) is multifaceted, requiring a comprehensive approach that includes patient history, physical examination, imaging studies, and laboratory tests. Clinicians must consider various factors and potential differential diagnoses to arrive at an accurate diagnosis and appropriate management plan. If you have further questions or need more specific information, feel free to ask!

Acquired atrophy of the ovary, classified under ICD-10 code N83.31, refers to the reduction in size and function of the ovaries due to various factors, including hormonal imbalances, surgical interventions, or other medical conditions. Understanding the standard treatment approaches for this condition involves a multi-faceted approach, focusing on the underlying causes, symptoms, and overall reproductive health.

Understanding Acquired Ovarian Atrophy

Acquired ovarian atrophy can occur due to several reasons, including:

• Hormonal Changes: Conditions such as menopause or hormonal disorders can lead to decreased ovarian function.
• Surgical Removal: Oophorectomy (removal of one or both ovaries) can result in atrophy of the remaining ovarian tissue.
• Radiation or Chemotherapy: Cancer treatments can damage ovarian tissue, leading to atrophy.
• Chronic Conditions: Certain chronic illnesses or endocrine disorders may also contribute to ovarian atrophy.

Standard Treatment Approaches

1. Hormone Replacement Therapy (HRT)

One of the primary treatments for acquired ovarian atrophy, especially in postmenopausal women, is hormone replacement therapy. HRT aims to restore hormonal balance and alleviate symptoms associated with low estrogen levels, such as:

• Hot flashes
• Vaginal dryness
• Mood swings

HRT can be administered in various forms, including pills, patches, gels, or vaginal rings, depending on the patient's needs and preferences[1].

2. Management of Underlying Conditions

If the atrophy is secondary to an underlying condition, such as a hormonal imbalance or chronic illness, addressing that condition is crucial. This may involve:

• Medications: For conditions like polycystic ovary syndrome (PCOS) or thyroid disorders, specific medications can help restore hormonal balance.
• Lifestyle Modifications: Weight management, exercise, and dietary changes can improve overall health and hormonal function, potentially reversing some effects of ovarian atrophy[2].

3. Fertility Treatments

For women experiencing infertility due to ovarian atrophy, assisted reproductive technologies (ART) may be considered. Options include:

• In Vitro Fertilization (IVF): This involves retrieving eggs from the ovaries and fertilizing them outside the body, then implanting the embryos into the uterus.
• Oocyte Donation: In cases where ovarian function is severely compromised, using donor eggs may be a viable option for achieving pregnancy[3].

4. Psychological Support

The emotional and psychological impact of acquired ovarian atrophy, particularly concerning fertility and menopause, should not be overlooked. Counseling or support groups can provide valuable resources for coping with these changes[4].

5. Regular Monitoring and Follow-Up

Regular follow-up with healthcare providers is essential to monitor the condition and adjust treatment plans as necessary. This may include:

• Ultrasound Evaluations: To assess ovarian size and function.
• Hormonal Assessments: Blood tests to evaluate hormone levels and adjust HRT accordingly[5].

Conclusion

The treatment of acquired ovarian atrophy (ICD-10 code N83.31) is tailored to the individual, focusing on restoring hormonal balance, managing underlying conditions, and addressing fertility concerns. Hormone replacement therapy remains a cornerstone of treatment, while lifestyle changes and psychological support play significant roles in overall management. Regular monitoring ensures that treatment remains effective and responsive to the patient's evolving needs. For those facing challenges related to fertility, assisted reproductive technologies offer hope and options for family planning.

By understanding the complexities of this condition and its treatment, patients can work closely with their healthcare providers to achieve the best possible outcomes.